BIOEN.E — Biotrend Cevre ve Enerji Yatirimlari AS Cashflow Statement
0.000.00%
- TRY9.73bn
- TRY13.59bn
- TRY2.69bn
- 39
- 14
- 73
- 33
Annual cashflow statement for Biotrend Cevre ve Enerji Yatirimlari AS, fiscal year end - December 31st, TRY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | R2022 December 31st | R2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 49.9 | 1.24 | 577 | 1,372 | 98.6 |
Depreciation | |||||
Non-Cash Items | 47.6 | 3.91 | 180 | -1,015 | 550 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -67 | -364 | -254 | 589 | -109 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Net Change in Other Assets & Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 53 | -326 | 800 | 1,585 | 1,259 |
Capital Expenditures | -287 | -441 | -1,447 | -1,511 | -692 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -43.7 | 1.1 | -0.671 | 101 | 12.8 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -331 | -440 | -1,448 | -1,410 | -679 |
Financing Cash Flow Items | -10.9 | -23.7 | -86.1 | -316 | 0.312 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 361 | 835 | 229 | -28.7 | -693 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 83.5 | 69.1 | -419 | 147 | -114 |